Mangoceuticals, Inc. (MGRX)
NASDAQ: MGRX · Real-Time Price · USD
0.4275
+0.0157 (3.81%)
Jul 20, 2026, 1:40 PM EDT - Market open
Mangoceuticals Employees
Mangoceuticals had 3 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
3
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$138,193
Profits / Employee
-$6,794,251
Market Cap
7.34M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 3 | 0 | - |
| Dec 31, 2024 | 3 | 0 | - |
| Dec 31, 2023 | 3 | 1 | 50.00% |
| Dec 31, 2022 | 2 | - | - |
| Sep 30, 2022 | 2 | - | - |
| Jun 30, 2022 | 2 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| CareCloud | 3,650 |
| Definitive Healthcare | 686 |
| VSee Health | 209 |
| DarioHealth | 165 |
| Mobile-health Network Solutions | 89 |
| Healthcare Triangle | 41 |
| Zhongchao | 33 |
| OneMedNet | 23 |
MGRX News
- 2 months ago - Mangoceuticals Quarterly report: Q1 2026 - Filings
- 3 months ago - Mangoceuticals Annual report: Q4 2025 - Filings
- 4 months ago - Why Is Mangoceuticals, Inc. Stock (MGRX) Up Today? - TipRanks
- 4 months ago - Mangoceuticals files civil lawsuit against Clarity Ventures - TheFly
- 4 months ago - Mangoceuticals Announces Lawsuit Seeking Damages Exceeding $73 Million Against Former Technology Consulting and Software Development Firm, Clarity Ventures, Inc. - GlobeNewsWire
- 4 months ago - Mangoceuticals announces patent filing for MGX-0024 - TheFly
- 4 months ago - Mangoceuticals, Inc. Announces PCT Patent Filing for MGX-0024 Antiviral Technology to Include Inhibiting Respiratory or Orally Acquired Virus Infection in Animals or Birds - GlobeNewsWire
- 5 months ago - Mangoceuticals' Patented MGX-0024 Achieves Zero Respiratory-Related Mortality in 29,000-Bird Field Trials and Demonstrates Prophylactic Benefit Against H5N1 in Controlled Government Study - GlobeNewsWire